<?xml version="1.0" encoding="UTF-8"?>
<p id="para420">Two patients (5%) died during the study, both in the GEM-P group, from lung infections. Up to Nov 7, 2017, 33 patients (39%) of 84 had died in the ITT population, 18 (44%) of 41 in the CHOP group (13 from disease progression and five from sepsis) and 15 (35%) of 43 in the GEM-P group (nine from disease progression, three from sepsis, one cardiac event, one from ischaemic colitis and disease progression, and one from metastatic cancer).</p>
